1. New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis;Korhonen;Br. J. Pharmacol.,2007
2. Human cytochromes P450 and their role in metabolism-based drug–drug interactions;Clarke,2002
3. Pharmacokinetics and metabolic drug interactions;Leucuta;Curr. Clin. Pharmacol.,2006
4. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians;Shimada;J. Pharmacol. Exp. Ther.,1994
5. Isoflurane–chlorodifluoroethene interaction in human liver microsomes: role of cytochrome P4502B6 in potentiation of halothane metabolism;Baker;Drug Metab. Dispos.,1995